(Q37969220)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22176624%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22176624%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Berit P Jensen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22176624%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22176624%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22176624%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22176624%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22176624%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

83-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22176624%20AND%20SRC:MED&resulttype=core&format=json

The role and impact of SNPs in pharmacogenomics and personalized medicine

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Pharmacogenetics, drug-metabolizing enzymes, and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Clinically available pharmacogenomics tests

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Clinical pharmacogenomics of thiopurine S-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Irinotecan pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Warfarin: almost 60 years old and still causing problems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Thymidylate synthase pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Superior antimalarial activity of proguanil to cycloguanil after in vitro bioconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.134